황반변성·망막

31개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved31 programs
AntibodyLimited DatastaleSaglik Bilimleri UniversitesiPreclinical

ranibizumab (Lucentis, dexamethasone implant versus ranibizumab)

Diabetic Macular Edema; Inflammation · Diabetic Macular Edema

#DiabeticMacularEdema#Antibody#Preclinical#monoclonal-antibody#Inflammation+1
Trials 1Status Active
AntibodyLimited DatastaleHawaii Pacific HealthPhase 2

ranibizumab (Lucentis, high-dose ranibizumab)

PCV; Polypoidal Choroidal Vasculopathy · PCV

#PCV#Antibody#Phase2#monoclonal-antibody#PolypoidalChoroidalVasculopathy+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

injection Combined Bevacizumab and Fasudil (injection Combined Bevacizumab and Fasudil)

Retinal Vein Occlusion · Retinal Vein Occlusion

#RetinalVeinOcclusion#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

injection bevacizumab (injection bevacizumab)

Retinal Vein Occlusion · Retinal Vein Occlusion

#RetinalVeinOcclusion#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleShahid Beheshti University of M…Phase 3

injection of bevacizumab (injection of bevacizumab)

Refractory Diabetic Macular Edema · FRα

#FR#Antibody#Phase3#monoclonal-antibody#RefractoryDiabeticMacularEdema+1
Trials 1Status Active
AntibodyLimited DatastaleShahid Beheshti University of M…Phase 3

injection of bevacizumab and erythropoietin (injection of bevacizumab and erythropoietin)

Refractory Diabetic Macular Edema · FRα

#FR#Antibody#Phase3#monoclonal-antibody#RefractoryDiabeticMacularEdema+1
Trials 1Status Active
CGTLimited DatastaleLions Eye Institute, Perth, Wes…Phase 2

rAAV.sFlt-1 (rAAV.sFlt-1)

Macular Degeneration; Age-related Maculopathies · Macular Degeneration

#MacularDegeneration#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

rAAV2-CBSB-hRPE65 (rAAV2-CBSB-hRPE65)

Amaurosis of Leber; Retinal Diseases · Amaurosis of Leber

#AmaurosisofLeber#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleDan LiangPhase 2

adalimumab (Humira, reduction or discontinuation of Adalimumab)

Uveitis; Adalimumab · Uveitis

#Uveitis#Antibody#Phase2#monoclonal-antibody#Adalimumab+1
Trials 1Status Active
AntibodyLimited DatastaleGenentech, Inc.Phase 3

ranibizumab (rhuFab V2, rhuFab V2 (ranibizumab))

Macular Degeneration · Macular Degeneration

#MacularDegeneration#Antibody#Phase3#monoclonal-antibody#Genentech
Trials 1Status Active
CGTLimited DatastaleUniversity College, LondonPhase 2

rAAV 2/2.hRPE65p.hRPE65 (tgAAG76, tgAAG76 (rAAV 2/2.hRPE65p.hRPE65))

Retinal Degeneration · Retinal Degeneration

#RetinalDegeneration#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active

2 / 2 pages

← PreviousNext →